Home/Filings/4/0000950170-23-047933
4//SEC Filing

Bryce Joanne 4

Accession 0000950170-23-047933

CIK 0001816736other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:15 PM ET

Size

6.8 KB

Accession

0000950170-23-047933

Insider Transaction Report

Form 4
Period: 2023-09-11
Bryce Joanne
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-11$9.86/sh+2,500$24,6503,760 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-09-112,50076,745 total
    Exercise: $9.86Exp: 2031-09-13Common Stock (2,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Disc Medicine, Inc.

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001951845

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:15 PM ET
Size
6.8 KB